September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Callie Coombs Discusses Updated CLL13 Data and Therapy Duration Implications for Clinical Practice
Jun 14, 2025, 07:12

Callie Coombs Discusses Updated CLL13 Data and Therapy Duration Implications for Clinical Practice

Callie Coombs, Associate clinical professor at University of California, Irvine, posted on X:

“CLL13 longer follow up – huge study and great presentation. Though GIV is superior, I would not use as SOC since the duration of therapy is longer (range 12-36 months) than ven/obi which is still quite excellent (and always 1 yr). And yes MRD still matters!”

Callie Coombs Discusses Updated CLL13 Data and Therapy Duration Implications for Clinical Practice

More posts featuring EHA 2025.